Capecitabine · Roche
Made in Switzerland
Sign in to see wholesale prices
Trade pricing and ordering are available to registered, verified healthcare practitioners, pharmacies, and clinics across Sri Lanka.
Xeloda (capecitabine) is an oral fluoropyrimidine carbamate antineoplastic developed by Roche. Each Xeloda 500mg tablet contains capecitabine 500mg, supplied in blister strips. Capecitabine is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) preferentially within tumour tissue, supporting its established role in the adjuvant and metastatic treatment of colorectal cancer, in metastatic breast cancer, and in the adjuvant treatment of gastric cancer in adult patients. Contact our wholesale team or place an order through the Lanka Chemist portal for current Xeloda 500mg pricing & availability.
Same medicine or similar products in stock